It: Welcome to Derry, a television series companion to the events of Stephen King’s It, is being developed for Max, and some ...

You’ll want to make sure you don’t leave the second chapter in this iconic story unopened. Jovan Adepo and Chris Chalk star in the television spinoff. This town only big enough for one type of ...

today announced the first patient has been dosed in the company’s Phase 2 clinical trial, the HORIZON Study, of MZE829 in patients with APOL1 kidney disease (AKD). MZE829 is an oral, small molecule ...

Notably, Chapter 2 Season 2 introduced players to espionage with characters such as Midas, and the season’s success was fueled by a spy-themed Battle Pass, covert missions, and the inclusion of ...

CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise.

Isaiah Mustafa hinted at the possibility of It: Chapter Three happening in the near future. Mustafa commented on the potential return of his character Mike Hanlon in a future installment.

In response to reports about a goat-eating dog being killed by hanging, the Justice Ministry said that the Mediation Board did not issue an order to that effect, but facilitated the mutually ...

If she goes, she risks not coming back to her family or her beloved island. Here's where Moana 2 really shows us how far Moana has grown. With age and greater status in Motunui, she's become far ...

The OG Chapter 1 Season 2 map has been revealed with iconic locations like Tilted Towers making a comeback. Fortnite OG has its own battle pass and seasons, mirroring the main game mode structure.

Warped Tour staples Simple Plan, Bowling for Soup, Pennywise, and Miss May I lead the lineup. By Jessica Lynch The Vans Warped Tour is making a highly anticipated return in 2025, celebrating its ...

The Sims, originally released in 2000, has never been available digitally on PC, while The Sims 2 (2004) hasn't been available since 2014. Both games will apparently arrive with all of their ...

Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a phase 2 trial. The Bay Area-based biotech unveiled its ambition earlier ...